We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




CT-Induced Cancer Poses Minimal Risk Compared to Risk of Dying from Disease

By HospiMedica International staff writers
Posted on 18 May 2012
Young patients who undergo chest or abdominopelvic computed tomography (CT) scanning are more than 35 times more likely to die of their disease than develop a radiation-induced cancer, according to a review of 23,359 patients, some of whom were scanned more than 15 times. More...


The analysis conducted at three hospitals in Boston (MA, USA), including Massachusetts General Hospital, revealed that in the chest CT group, 575 out of 8,133 patients were deceased after a mean follow-up of about four years. “That compares to the 12 cases of radiation-induced cancer that would be expected in this group based on the BEIR-VII method, a commonly used model for determining CT-induced cancer incidence,” said Rob Zondervan, a medical student at the University of New England (Biddeford, ME, USA), and one of the authors of the study.

In the abdominopelvic CT group, 1,124 out of 15,226 patients were deceased after a mean follow-up of about 3.5 years. “That compares to 23 cases of predicted cancer incidence,” said Dr. Zondervan. “Our results indicate that the risk from underlying disease overshadows risk from CT radiation-induced malignancy, even in young adults,” he said.

Records of all patients aged 18-35 who underwent a chest CT or an abdominopelvic CT from 2003-2007 were included in the analysis. The data were additionally broken down based on number of CT scans. Patients who had only one or two scans had the most projected cases of CT-induced cancer (20 out of the 35 predicted cases). “This seeming anomaly arises from the much greater number of young adults who get one or two scans,” said Mr. Zondervan. “These results do emphasize that we need to focus our radiation reduction efforts on patients who are very rarely scanned as well as those who are more frequently scanned,” he said.
The study’s findings were presented at the American Roentgen Ray Society (ARRS) annual meeting May 1, 2012, held in Vancouver (BC, Canada).

Related Links:

Massachusetts General Hospital

University of New England




Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Cardiograph Device
PageWriter TC35
Radiology System
Riviera SPV AT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.